Latest Research in Ferroptosis and cancer prognosis
41 research papers · 2026 median publication year
Top Research Topics in Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis — 8 papers
- Cancer, Hypoxia, and Metabolism — 7 papers
- Mitochondrial Function and Pathology — 3 papers
- Amino Acid Enzymes and Metabolism — 2 papers
- Immune cells in cancer — 2 papers
- Extracellular vesicles in disease — 2 papers
- Telomeres, Telomerase, and Senescence — 2 papers
- Saffron Plant Research Studies — 1 papers
- Exercise and Physiological Responses — 1 papers
- Cancer, Lipids, and Metabolism — 1 papers
Highest-Cited Papers
- The assembly of tetrameric human L‐lactate dehydrogenase is regulated by ionic strength, β‐ NADH binding, cyclic peptides, and long‐chain dicarboxylates
- Adaptive response to serine and glycine deprivation enhances the stemness potential of pancreatic cancer cells
- A Novel Preclinical Mouse Model of Voluntary Active Stretching Suppresses Mammary Tumor Progression
- Epigenomic Remodeling by Lipid Metabolism: A Cross-Disease Perspective on Cancer and Brain Disorders
- TET2 as an epigenetic signaling hub: interactome networks, metabolic control and therapeutic vulnerabilities in hematologic malignancies
- Integrating UHPLC-MS and MALDI-MSI for Spatial Nucleoside Profiling in FFPE Breast Cancer: A Multimodal Molecular Pathology Framework
- Beyond Cys65: Redox Effector Factor-1 CRISPR-Engineered Cys93 and Cys99 Mutants Reveal Cooperative and Secondary Roles of Redox Signaling and Pancreatic Ductal Adenocarcinoma Progression
- Targeting Metabolic Pathways to Direct T-Cell Trafficking: Therapeutic Perspectives
- Erythropoietin in Tumor Immunity: Mechanistic Evidence, Clinical Cautions, and Translational Opportunities
- Targeting metabolic reprogramming in persister cancer cells: Emerging insights and therapeutic opportunities
- Mitochondrial metabolic reprogramming drives tumor immune evasion: regulatory mechanisms and targeting strategies
- HDCA suppresses exosomal lncRNA MSTRG171708 release to inhibit Treg-mediated immunometabolism in hepatocellular carcinoma
- AMPKα regulates glycolytic reprogramming to sustain NK cell proliferation and effector function
- From metabolic remodeling to therapeutic intervention: research progress on SLC7A5 in cancer
- In Vitro Glutamine Adaptability in Murine Liver- but Not Lung-Metastasizing Triple-Negative Breast Cancer Cells
- RNA sequencing of serum small extracellular vesicles from patients with intrahepatic cholangiocarcinoma and healthy controls
- ADCK1 Regulates Mitochondrial Bioenergetics in Hepatocellular Carcinoma In Vitro
- Deubiquitination of NICD1 by USP10 Restrains Esophageal Cancer: A Link Between NOTCH1 Stabilization, Oxidative Stress, and Ferroptosis
- NFS1 activates PI3K/AKT/mTOR signaling to upregulate GPX4 expression and enhance ferroptosis resistance in osteosarcoma
- Cell-based therapies of autoimmune diseases in the context of artificial intelligence development